Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence
- PMID: 8301426
- DOI: 10.1016/s0022-3476(94)70307-8
Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence
Abstract
Because a cluster of cases of Guillain-Barré syndrome followed a mass vaccination program using oral polio vaccine, a retrospective epidemiologic survey was carried out in southern California to examine the relationship between oral polio vaccine and Guillain-Barré syndrome. We also examined the yearly pattern of Guillain-Barré syndrome and compared rates of illness in different ethnic populations. The mean annual incidence of Guillain-Barré syndrome was 0.60 (95% confidence intervals 0.48 to 0.73) per 100,000 children under 15 years of age. There was no difference in incidence between boys and girls or between ethnic populations. The incidence was significantly higher in 2-year-old children than in any other age group (p < 0.05). The onset of Guillain-Barré syndrome was preceded by an infection in 71 (76%) of 93 children. In five children (5%) a vaccination was given within 8 weeks before illness onset. Only two children received the oral polio vaccine; the duration from vaccine administration to the onset of Guillain-Barré syndrome was 41 and 52 days, whereas the mean incubation time associated with infectious illnesses was 10.3 days. Strong evidence against a causal relationship between oral polio vaccine administration and Guillain-Barré syndrome is provided by the failure to find a correlation between the usual age of immunization with oral polio vaccine and the incidence of Guillain-Barré syndrome by age and the failure to find any children with onset of Guillain-Barré syndrome within 1 month of immunization with oral polio vaccine.
Similar articles
-
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.Am J Public Health. 1997 Dec;87(12):2045-8. doi: 10.2105/ajph.87.12.2045. Am J Public Health. 1997. PMID: 9431302 Free PMC article. Review.
-
An epidemiologic, clinical, and therapeutic study of childhood Guillain-Barré syndrome in Kuwait: is it related to the oral polio vaccine?J Child Neurol. 1998 Oct;13(10):488-92. doi: 10.1177/088307389801301004. J Child Neurol. 1998. PMID: 9796754
-
Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome.Am J Epidemiol. 1998 Jan 1;147(1):69-73. doi: 10.1093/oxfordjournals.aje.a009369. Am J Epidemiol. 1998. PMID: 9440401
-
Incidence of Guillain-Barré syndrome during a nationwide oral poliovirus vaccine campaign.Neurology. 1989 Aug;39(8):1034-6. doi: 10.1212/wnl.39.8.1034. Neurology. 1989. PMID: 2788248
-
Epidemiology of Guillain-Barré syndrome.Adv Neurol. 1978;19:249-60. Adv Neurol. 1978. PMID: 369322 Review.
Cited by
-
Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.Arch Dis Child. 2007 Jan;92(1):48-52. doi: 10.1136/adc.2006.098061. Epub 2006 Aug 18. Arch Dis Child. 2007. PMID: 16920757 Free PMC article.
-
Assessment of autonomic dysfunction in childhood guillain-barré syndrome.J Cardiovasc Thorac Res. 2013;5(3):81-5. doi: 10.5681/jcvtr.2013.018. Epub 2013 Oct 5. J Cardiovasc Thorac Res. 2013. PMID: 24252981 Free PMC article.
-
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.Am J Public Health. 1997 Dec;87(12):2045-8. doi: 10.2105/ajph.87.12.2045. Am J Public Health. 1997. PMID: 9431302 Free PMC article. Review.
-
Clinical characteristics of childhood guillain-barré syndrome.Oman Med J. 2008 Jul;23(3):158-61. Oman Med J. 2008. PMID: 22359705 Free PMC article.
-
Bladder dysfunction and hypertension in children with Guillain-Barre syndrome.Pediatr Nephrol. 2014 Sep;29(9):1637-41. doi: 10.1007/s00467-014-2799-2. Epub 2014 Mar 22. Pediatr Nephrol. 2014. PMID: 24651942
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources